University of Utah

Top Computer Scientists Join Style3D's Global Dream Team, enhancing its Innovation Capacity in 3D Simulation and AI Technology

Retrieved on: 
화요일, 10월 17, 2023
Multimedia, Princeton University Department of Mathematics, Moses Austin, University of Utah, AI, UCLA, University, Animation, NSF, Computer graphics, National Science Foundation, Dream Team, Computer science, Industrial design, Medical device, Mobile phone, Mathematics, Engineering

This strategic decision aligns with Style3D's goal of strengthening its Dream Team, which aims to push the boundaries of 3D simulation and AI technology in digital fashion.

Key Points: 
  • This strategic decision aligns with Style3D's goal of strengthening its Dream Team, which aims to push the boundaries of 3D simulation and AI technology in digital fashion.
  • Additionally, this move involves the establishment of StyleU Lab, which is now operating in Salt Lake City, Utah.
  • The Two "Graphics Masters" that Have Joined Style3D's Dream Team Are:
    Dr. Yin Yang, an associate professor in the John and Marcia Price College of Engineering, University of Utah.
  • "Style3D Research Institute has been committed to bringing more innovation in the technology and application of computer graphics.

Top Computer Scientists Join Style3D's Global Dream Team, enhancing its Innovation Capacity in 3D Simulation and AI Technology

Retrieved on: 
화요일, 10월 17, 2023
Princeton University Department of Mathematics, Moses Austin, University of Utah, AI, UCLA, University, Animation, NSF, Computer graphics, National Science Foundation, Dream Team, Computer science, Industrial design, Medical device, Mathematics, Engineering

This strategic decision aligns with Style3D's goal of strengthening its Dream Team, which aims to push the boundaries of 3D simulation and AI technology in digital fashion.

Key Points: 
  • This strategic decision aligns with Style3D's goal of strengthening its Dream Team, which aims to push the boundaries of 3D simulation and AI technology in digital fashion.
  • Additionally, this move involves the establishment of StyleU Lab, which is now operating in Salt Lake City, Utah.
  • The Two "Graphics Masters" that Have Joined Style3D's Dream Team Are:
    Dr. Yin Yang, an associate professor in the John and Marcia Price College of Engineering, University of Utah.
  • "Style3D Research Institute has been committed to bringing more innovation in the technology and application of computer graphics.

Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen

Retrieved on: 
금요일, 10월 13, 2023
Surgery, Medical Devices, Hospitals, Health, Health Technology, Linda, Multimedia, MASI, Desaturation, De novo, US, University of Utah, De novo gene birth, MD, Ori, Motion, Blood gas tension, Apnea, University, Hyperoxia, Intensive care medicine, American Medical Association, FDA, CE marking, Masimo, Oxygen, Oxygen saturation (medicine), Anesthesia & Analgesia, Pulse, Airway management, Patient, Medical device, Compact Disc manufacturing, RD, Anesthesia, Anesthesiology, Pain management

Masimo (NASDAQ: MASI) today announced that ORi™, a noninvasive, continuous parameter designed to provide additional insight into a patient’s oxygen status in the moderate hyperoxic range under supplemental oxygen, has been granted a De Novo by the FDA.

Key Points: 
  • Masimo (NASDAQ: MASI) today announced that ORi™, a noninvasive, continuous parameter designed to provide additional insight into a patient’s oxygen status in the moderate hyperoxic range under supplemental oxygen, has been granted a De Novo by the FDA.
  • Enabled by the multi-wavelength Masimo rainbow® Pulse CO-Oximetry platform, ORi is designed for use in conjunction with oxygen saturation (SpO2) to provide increased resolution of changes in oxygenation under supplemental oxygen.
  • View the full release here: https://www.businesswire.com/news/home/20231013679815/en/
    Without ORi, there is no noninvasive way to monitor oxygenation under supplemental oxygen to manage hyperoxia, or higher than normal oxygenation of arterial blood.
  • By convention, SpO2 is limited to an upper limit of 100%, but oxygenation can rise into hyperoxia when supplemental oxygen is administered.

Lucy Therapeutics Expands Cutting-Edge Medical Research Program

Retrieved on: 
수요일, 10월 11, 2023
Health, Other Health, Other Science, General Health, Research, Science, Biotechnology, Walking, Eating, Biomarker, Hope, IRSF, University of Utah, Genetics, University, McGruder, Disease, Speech, Factorization of polynomials, Patient, Bangladesh Technical Education Board, Drug discovery, DSM-IV codes, Rett syndrome, Pharmaceutical industry

Lucy Therapeutics (LucyTx) has secured new funding from the International Rett Syndrome Foundation (IRSF) to invest in pioneering treatments for children and adults living with Rett syndrome, and to grow LucyTx’s groundbreaking treatment platform.

Key Points: 
  • Lucy Therapeutics (LucyTx) has secured new funding from the International Rett Syndrome Foundation (IRSF) to invest in pioneering treatments for children and adults living with Rett syndrome, and to grow LucyTx’s groundbreaking treatment platform.
  • Rett syndrome affects brain development in infants and toddlers, with missed growth milestones or regression typical around six to 18 months.
  • “A treatment that can help stop Rett syndrome will help improve so many lives.” Hallsey wrote a children’s book, “Matilda McGruder,” in 2021 that benefitted Rett syndrome research.
  • IRSF is a mission-driven advocacy foundation focused on funding research and supporting families impacted by Rett syndrome.

Tower Arch Capital Announces New Partner and Principal

Retrieved on: 
화요일, 9월 26, 2023
Jefferies Financial Group, Marketing, Deutsche Bank, Wharton School of the University of Pennsylvania, Bachelor of Economics, SALT, Associate, McKinsey & Company, Brigham Young University, Business administration, Investment, University, Harvard Business School, University of Utah, UBS, Master of Accountancy, Master of Business Administration, Management, Science, Economics, Partner, Accounting

Prior to rejoining Tower Arch Capital, he was a Principal at The Halifax Group.

Key Points: 
  • Prior to rejoining Tower Arch Capital, he was a Principal at The Halifax Group.
  • Prior to joining Tower Arch Capital, he worked for McKinsey & Company where he advised clients on topics including merger management, marketing and sales, and product development.
  • Rhett Neuenschwander, Partner at Tower Arch Capital, said, "We are thrilled to announce the promotions of David and James.
  • Both have made significant contributions to Tower Arch as they have worked on new investments and with existing portfolio companies.

The Big Reveal: Global University Visibility (GUV) Rankings Announce Top 300 Universities

Retrieved on: 
화요일, 9월 19, 2023
University of Southern California, Central Florida, Indiana University, University, Virginia Tech, Harvard University, Monash University, London School of Economics, University of Queensland, MIT, Dartmouth College, University of Georgia, GUV, University of Utah, RWTH Aachen University, Ivy League, University of Houston, 182nd Infantry Regiment (United States), United Kingdom, University of Central Florida, Cornell University, KU Leuven, Economics, University of New South Wales, Northeastern University

WASHINGTON , Sept. 19, 2023 /PRNewswire/ -- The Global University Visibility (GUV) Rankings have revealed their list of the world's most renowned educational institutions, expanding beyond the Top 100 to include 300 prominent universities across the globe.

Key Points: 
  • WASHINGTON , Sept. 19, 2023 /PRNewswire/ -- The Global University Visibility (GUV) Rankings have revealed their list of the world's most renowned educational institutions, expanding beyond the Top 100 to include 300 prominent universities across the globe.
  • The GUV Ranking by American Caldwell offers a closer look into the universities commanding the most mindshare and visibility in 2023.
  • The additions hail from Australia (Monash University, UNSW Sydney, University of Queensland), Belgium (KU Leuven), China (Zhejiang), Germany (RWTH Aachen), the United Kingdom (London School of Economics), and the United States (Indiana University, Arizona State, Michigan State, University of Southern California, University of Central Florida, University of Georgia, Northeastern University, Virginia Tech, University of Utah, and University of Houston).
  • While Harvard University tops the list with a visibility score that is 30% higher than MIT's score in second place, Cornell University holds only a 0.27% edge over the University of Toronto, which ranks fifth.

Charting the Future of Data Storage: DSPA-Asia Bootcamp by GreaterHeat

Retrieved on: 
수요일, 9월 13, 2023
Titan, Single (music), University, Huawei, Curriculum, British Armed Forces communications and information systems, History, Swissôtel The Stamford, USC Shoah Foundation, Port and starboard, PIB, University of Utah, Data onboarding, Berkeley, InterPlanetary File System, Growth, AI, Ecosystem, Cryptocurrency, Web3, LDN, Filecoin, Boot camp

DSPA-Asia serves as a pivotal business incubator, empowering AI and Web3 data storage enterprises in Asia to learn, grow, and flourish.

Key Points: 
  • DSPA-Asia serves as a pivotal business incubator, empowering AI and Web3 data storage enterprises in Asia to learn, grow, and flourish.
  • Central to this initiative is the DSPA-Asia Bootcamp, a comprehensive 6-month training program designed to equip data storage providers with professional support and services, enabling them to tackle challenges, expand their data operations, and scale their Filecoin data storage capacities.
  • Since 2022, GreaterHeat has successfully provided decentralized AI and Web3 data storage solutions to companies across the United States, Canada, and Europe utilizing Filecoin.
  • It is poised to accelerate the transformation of the data storage market, rendering data more valuable to individuals and entities alike.

America First Credit Union Unveils Official Utah Athletics Branded Visa Debit Card

Retrieved on: 
화요일, 8월 22, 2023
University, America First, SALT, AFCU, University of Utah, America First Credit Union, Classic, Credit union, Rice–Eccles Stadium, Sport, Online shopping, Athletics

SALT LAKE CITY, Aug. 22, 2023 /PRNewswire/ -- University of Utah Athletics fans have a new way to support their favorite team with the help of America First Credit Union. As the official credit union of the University of Utah Athletics, America First announced the official Utah Athletics debit card. The card features the Utah logo on a sleek white background with a visible crimson core, allowing cardholders to show off their Utah pride with every purchase.  

Key Points: 
  • As the official credit union of the University of Utah Athletics, America First announced the official Utah Athletics debit card.
  • "We're thrilled that America First Credit Union has introduced the Utah Athletics debit card," said Mark Harlan, Director of Athletics.
  • Packed with features, benefits, and discounts, the Utah Athletics debit card is available with both America First's Classic and Premium Checking accounts.
  • To learn more or get the exclusive Utah Athletics debit card, visit americafirst.com/uofu .

Mill Creek Announces Expansion into Utah Market

Retrieved on: 
화요일, 8월 22, 2023
University of Utah, Colliers (company), Tyler Greene, University, Surface area, SALT, Canal, Phoenix

SALT LAKE CITY, Aug. 22, 2023 /PRNewswire/ -- Mill Creek Residential, a leading developer, owner-operator and investment manager specializing in premier rental housing across the U.S., today announced its expansion into Utah and the greater Salt Lake City market. 

Key Points: 
  • SALT LAKE CITY, Aug. 22, 2023 /PRNewswire/ -- Mill Creek Residential , a leading developer, owner-operator and investment manager specializing in premier rental housing across the U.S., today announced its expansion into Utah and the greater Salt Lake City market.
  • "I'm thrilled to oversee Mill Creek's expansion efforts into Salt Lake City, which I believe will prove to be a tremendous location for us," Greene said.
  • "Salt Lake City generally fares well through national real estate challenges, which is part of what makes it an attractive market."
  • Mill Creek is actively pursuing development opportunities within the Salt Lake City area and expects to soon announce plans for its first community in the market.

Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer

Retrieved on: 
월요일, 8월 21, 2023
Biotechnology, Other Health, Health, General Health, Pharmaceutical, Oncology, Men, Research, Consumer, Science, Clinical Trials, IPN, Medical Affairs Bureau, University, ADR, Progression-free survival, Prostate cancer, OS, Cancer, Immunotherapy, PFS, University of Utah, Huntsman Cancer Institute, Professor, Patient, Exelixis, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, EXEL, Medical imaging, Pharmaceutical industry, Ipsen, Euronext

CONTACT-02 is evaluating cabozantinib (CABOMETYX®) in combination with atezolizumab compared with a second novel hormonal therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) and measurable soft tissue disease who have been previously treated with one novel hormonal therapy.

Key Points: 
  • CONTACT-02 is evaluating cabozantinib (CABOMETYX®) in combination with atezolizumab compared with a second novel hormonal therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) and measurable soft tissue disease who have been previously treated with one novel hormonal therapy.
  • Therefore, the trial will continue to the next analysis of OS as planned.
  • The safety profile of the combination of cabozantinib and atezolizumab was consistent with the known safety profiles for each single medicine, and no new safety signals were identified with the combination.
  • “These results represent the first positive phase 3 data of its kind for a tyrosine kinase inhibitor and immunotherapy combination in this indication.